Symbols / CTIC
CTIC Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire Fri, 14 Nov 2025 08
- Brainstorm Cell Therapeutics Announces New Private Placement Financing - The Globe and Mail Sat, 14 Feb 2026 08
- Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy - Seeking Alpha hu, 13 Nov 2025 08
- How Low Can Lineage Cell Therapeutics Stock Really Go? - Trefis Sun, 21 Dec 2025 08
- Earnings call transcript: Lineage Cell Therapeutics Q3 2025 reveals earnings miss - Investing.com hu, 06 Nov 2025 08
- Lineage Cell Therapeutics Issues Letter to Stockholders - Business Wire Mon, 05 Jan 2026 08
- BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire hu, 14 Aug 2025 07
- CTI BioPharma Stock Soars on Deal to Be Acquired for $1.7 Billion - Barron's Wed, 10 May 2023 07
- Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire ue, 12 Aug 2025 07
- European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B - Yahoo Finance Wed, 10 May 2023 07
- BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB - PR Newswire hu, 17 Jul 2025 07
- Satellite-based Agriculture Data - The Nature Conservancy Fri, 19 Apr 2024 07
- CTI BioPharma (CTIC) Stock Price, News & Analysis $CTIC - MarketBeat hu, 11 Jun 2015 09
- Cell Therapeutics, Inc. Announces Change Of Name To CTI BioPharma Corp. - BioSpace Fri, 30 May 2014 07
- CTI BioPharma (CTIC) Stock Could Hit $6, Says Analyst - TipRanks hu, 01 Oct 2020 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CTIC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|